Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Booster in 14-15-year-old children
NCT00870350Phase 4Unknown
- Sponsor
- Swedish Institute for Infectious Disease Control
- Start
- Apr 2009
- Primary completion
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of diphtheria, tetanus, and acellular pertussis vaccine, tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Swedish Institute for Infectious Disease Control. Status: unknown.
02
Drugs
diphtheria, tetanus, and acellular pertussis vaccinetetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT00870350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870350.